Navigation Links
Fruitfly study: Epilepsy drug target implications for sleep disruption in brain disorders
Date:4/1/2014

PHILADELPHIA A new study in a mutant fruitfly called sleepless (sss) confirmed that the enzyme GABA transaminase, which is the target of some epilepsy drugs, contributes to sleep loss. The findings, published online in Molecular Psychiatry, were led by Amita Sehgal, PhD, head of the Chronobiology Program at the University of Pennsylvania's Perelman School of Medicine. The findings shed light on mechanisms that may be shared between sleep disruption and some neurological disorders. A better understanding of this connection could enable treatments that target both types of symptoms and perhaps provide better therapeutic efficacy.

"Epilepsy is essentially an increase-in-firing disorder of the brain and maybe a decrease in activity of the neurotransmitter GABA, too," says Sehgal, who is also a professor of Neuroscience and an investigator with the Howard Hughes Medical Institute (HHMI). "This connects our work to drugs that inhibit GABA transaminase. Changes in GABA transaminase activity are implicated in epilepsy and some other psychiatric disorders, which may account for some of the associated sleep problems."

The team looked at the proteomics of the sss mutant brain a large-scale study of the structure and function of related proteins -- and found that GABA transaminase is increased in the sss brain compared to controls. This enzyme breaks down GABA, so GABA is decreased in the sss brain. Because GABA promotes sleep, there is a decrease in sleep in the sss mutant fly, as the name implies.

The relationship between the SSS protein and GABA is not fully understood. The SSS protein controls neural activity, and its absence results in increased neural firing, which likely uses up a lot of energy, says Sehgal. GABA transaminase works in the mitochondria, the energy-production organelle in the glial cells of the brain, which provide fuel for neurons. The large energy demand created by the increased neural firing in sss brains probably alters mitochondrial metabolism, including GABA transaminase function in glia.

In the sss mutant fly, there is a stream of connections that leads to its signature loss of sleep: The sss mutant has increased neuron firing caused by downregulation of a potassium channel protein called Shaker. Recently, the Sehgal lab showed that SSS also affects activity of acetylcholine receptors. Both of these actions may directly cause an inability to sleep. In addition, increased energy demands on glia, which increase GABA transaminase and decrease GABA, may further contribute to sleep loss. On the other hand, if GABA is increased, then sleep is increased, as in flies that lack GABA transaminase.


'/>"/>

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
Source:Eurekalert  

Related medicine news :

1. IU, Regenstrief study: New noninvasive colorectal cancer screening tool highly accurate
2. Study: MLB pitchers dont regain performance level after Tommy John surgery
3. Study: Resilience in parents of children undergoing stem cell transplant
4. U of Maryland study: Partnership may help address cancer, health disparities
5. Study: Oropharyngeal cancer on the rise in young adults
6. Johns Hopkins study: Traumatic spinal cord injuries on the rise in US
7. Regenstrief, IU study: Half of hospitalized adults over 65 need surrogate decision-makers
8. Study: Possible new druggable target in Ewings Sarcoma
9. Study: Autophagy predicts which cancer cells live and die when faced with anti-cancer drugs
10. Study: Living Room offers alternative treatment for emotional distress
11. Study: Half of black males, 40 percent of white males arrested by age 23
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Fruitfly study: Epilepsy drug target implications for sleep disruption in brain disorders
(Date:12/7/2016)... MI (PRWEB) , ... December 07, 2016 , ... ... and financial consultation services from offices located in South Lyon, Dewitt, Williamston, East ... benefit a basketball coach who needs treatment for a brain tumor. , Jason ...
(Date:12/7/2016)... ... December 07, 2016 , ... A. Kevin Spann Insurance, a New York-based ... Five Boroughs, is launching a charity drive to raise funds that will benefit the ... spirit of marines and Navy FMF Corpsmen. Working closely with the MCL, the A. ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... Delete® - ... in Time For The Holiday Party Season. Save Up To 33% Off Botox® and ... Salon is providing the Phoenix Valley with Delightful Deals on Botox® and ...
(Date:12/7/2016)... ... December 07, 2016 , ... Gensuite is ... Awards under the Best New Product Launch category. Gensuite’s entry on their EZ ... , BOC Global Events & Training Group is a professional event and training ...
(Date:12/7/2016)... ... 07, 2016 , ... “Walking With God: Inspirational Lessons from My Life's Journey”: ... to be aware of God's direction in their lives. “Walking With God: Inspirational Lessons ... and active church leader. , Sanford says, “I enjoy sharing the true ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... 6, 2016 Radioisotopes are radioactive isotopes having ... either by using nuclear research reactor or by using ... alpha, beta or gamma when changed to a stable ... Nuclear medicine, specifically in medical diagnostics. In this field, ... a human body,s functioning. Radiotherapy is also used to ...
(Date:12/6/2016)... Anaplastic Oligoastrocytoma - Pipeline Review, H2 ... Pharmaceutical and Healthcare disease pipeline guide Anaplastic Oligoastrocytoma ... of the Anaplastic Oligoastrocytoma (Oncology) pipeline landscape. ... when two types of cells in the brain, ... to form a mass. These brain cells are ...
(Date:12/6/2016)... Dec. 6, 2016   AlloSource , one ... bone, skin and soft-tissue allografts for use in ... Process Manager, for being named to the Board ... Quality Award by the Commerce Department,s National Institute ... commitment to process excellence. The Baldrige Award is ...
Breaking Medicine Technology: